EquatorVision (@equatorvision) 's Twitter Profile
EquatorVision

@equatorvision

EQUATΘR is an international collaboration bringing together world leaders from the field of clinical uveitis, image analysis, and outcome methodology.

ID: 1048206379545219073

linkhttp://www.equator.vision calendar_today05-10-2018 13:40:50

51 Tweet

50 Followers

24 Following

EquatorVision (@equatorvision) 's Twitter Profile Photo

Brilliant opening to the ‘Objective Measures of Intraocular Inflammation for Use in Clinical Trials’ meeting at UCLA UCLA Luskin Center for Innovation Doheny Eye Institute #ucla #uveitis #ophthalmology #opthalmologyresearch

Brilliant opening to the ‘Objective Measures of Intraocular Inflammation for Use in Clinical Trials’ meeting at <a href="/UCLA/">UCLA</a> <a href="/LuskinCenter/">UCLA Luskin Center for Innovation</a> <a href="/DohenyEye/">Doheny Eye Institute</a> #ucla #uveitis #ophthalmology #opthalmologyresearch
EquatorVision (@equatorvision) 's Twitter Profile Photo

Tom McNally summarises the evidence on instrument based measures of AC flare and aqueous proteins at #uveitis endpoints workshop

Tom McNally summarises the evidence on instrument based measures of AC flare and aqueous proteins at #uveitis endpoints workshop
Alastair Denniston (@denniston_ophth) 's Twitter Profile Photo

EquatorVision An important milestone in moving the care of patients with #uveitis to the modern era. We're aiming to replace traditional clinician guesstimates with measures that are sensitive, objective and reliable. Thanks Gary for your vision and hard work.

Ophthalmology at BMJ (@bmj_ophth) 's Twitter Profile Photo

Uncertainty amongst #uveitis specialists on the management of childhood non-infectious chronic anterior uveitis in the UK. This study highlights the need for research to improve outcomes and provide evidence based medicine Dr Lola Solebo 💙👶🏾👁️👩🏾‍💻. ow.ly/V5ys30oEjfF

Dr Tas Braithwaite (@tasbraithwaite) 's Twitter Profile Photo

This weekend ICD-11 has been officially presented to Member States at the 2019 World Health Assembly. I hope the added granularity in the ICD-11 definitions for vision impairment better guides the data we need to impact avoidable vision loss globally icd.who.int/en/

OrphanetJournal at BMC (@ojrarediseases) 's Twitter Profile Photo

Under-utilization of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research, reviewed in OJRD #RareDisease ojrd.biomedcentral.com/articles/10.11…

Crabb Lab Research (@crabblab) 's Twitter Profile Photo

Important new research in @AmJOphthalmol shows #glaucoma patients with #uveitis have faster visual field loss than those without ajo.com/article/S0002-… @TweetIGA Uveitis Support Congrats 2 authors Xiao Liu Stephen Kelly Giovanni Montesano Susan Bryan Pearse Keane Alastair Denniston

Dr Lola Solebo 💙👶🏾👁️👩🏾‍💻 (@lolaeyedoc) 's Twitter Profile Photo

Many children with #uveitis can’t tell when things are active - that’s why eye checks in #JIA are so important - but some children & young people CAN feel it. Please help us shine a light on this🕵🏾‍♀️Thank you ⁦Uveitis Support⁩ & ⁦@JIA_Matters⁩!

Many children with #uveitis can’t tell when things are active - that’s why eye checks in #JIA are so important - but some children &amp; young people CAN feel it. Please help us shine a light on this🕵🏾‍♀️Thank you ⁦<a href="/OliviasVision/">Uveitis Support</a>⁩ &amp; ⁦@JIA_Matters⁩!
Fight for Sight (@fightforsightuk) 's Twitter Profile Photo

We've convened the UK’s leading ophthalmologists to draw attention to the ‘1:20 funding gap’ in eye research. A public letter published in today’s Guardian, calls on the new government to develop a national plan on sight loss. Read more here 👉 ow.ly/bEPR50xOeqJ

We've convened the UK’s leading ophthalmologists to draw attention to the ‘1:20 funding gap’ in eye research. A public letter published in today’s Guardian, calls on the new government to develop a national plan on sight loss. Read more here 👉 ow.ly/bEPR50xOeqJ
The Lancet Rheumatology (@thelancetrheum) 's Twitter Profile Photo

Tocilizumab in patients with anti-TNF refractory juvenile idiopathic #arthritis-associated #uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial thelancet.com/journals/lanrh… #LancetRheumatology #OpenAccess #JIA @VersusArthritis

Tocilizumab in patients with anti-TNF refractory juvenile idiopathic #arthritis-associated #uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial thelancet.com/journals/lanrh… #LancetRheumatology #OpenAccess #JIA @VersusArthritis
UveitisCSG (@uveitiscsg) 's Twitter Profile Photo

Uveitis CSG guidance on #uveitis patients during #COVID19 pandemic. Created in partnership with paed+adult rheumatologists, NHSE for a unified cross-disciplinary response. uveitisstudygroup.org/covid19

Uveitis CSG guidance on #uveitis patients during #COVID19 pandemic.

Created in partnership with paed+adult rheumatologists, NHSE for a unified cross-disciplinary response.

uveitisstudygroup.org/covid19
ASTUTE Trial (@astutetrial) 's Twitter Profile Photo

Introducing the ASTUTE trial, sponsored by University Hospitals Bristol and Weston NHS FT - a randomised controlled trial looking at #adalimumab for the treatment of #autoimmune #uveitis. The trial is in set up and we look forward to bringing you more news soon! Follow us to stay up to date. Andrew Dick Abby Ocon

Introducing the ASTUTE trial, sponsored by <a href="/uhbwNHS/">University Hospitals Bristol and Weston NHS FT</a> - a randomised controlled trial looking at #adalimumab for the treatment of #autoimmune #uveitis. The trial is in set up and we look forward to bringing you more news soon! Follow us to stay up to date. <a href="/andrewdick4/">Andrew Dick</a> <a href="/Abby_OCon/">Abby Ocon</a>